Bank of New York Mellon Corp - TITAN PHARMACEUTICALS INC DE ownership

Back to all holdings Add to watchlist

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q2 2021$40,000
-25.9%
15,397
-15.4%
0.00%–
Q1 2021$54,000–18,204–0.00%–
 Download
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2021
NameSharesValueWeighting ↓
Newbridge Financial Services Group, Inc. 2$10.00%
Westside Investment Management, Inc. 4$20.00%
Global Wealth Strategies & Associates 40$190.00%
Cape Investment Advisory, Inc. 1$00.00%
JPMORGAN CHASE & CO 157$730.00%
Nemes Rush Group LLC 1$10.00%
Renaissance Technologies 135,710$640.00%
VANGUARD GROUP INC 82,051$38,8920.00%
UBS Group AG 4$20.00%
OSAIC HOLDINGS, INC. 50$220.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders